the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Prince Andrew leaves Windsor home amid renewed Epstein scrutiny

Prince Andrew moves from Royal Lodge to Sandringham estate as pressure mounts over his links to Jeffrey Epstein and calls for US Congress testimony

LONDON: Britain’s former prince Andrew has moved from his Windsor home to a royal estate in eastern England, the BBC reported.

The ex-royal, now known as Andrew Mountbatten-Windsor, left Royal Lodge on Monday according to the broadcaster.

He had been living at the property close to Windsor Castle with his ex-wife Sarah Ferguson for the past two decades.

Andrew is reportedly living in a temporary home at the Sandringham estate in Norfolk.

Pressure on the former royal has intensified since he appeared in a new cache of documents related to the late sex offender Jeffrey Epstein released by the US Justice Department.

It includes photos of the then-prince kneeling over a woman lying on the ground, and emails inviting Epstein to Buckingham Palace.

The revelations prompted Prime Minister Keir Starmer to say Andrew should testify before the US Congress.

A second Epstein victim has claimed through her lawyer that the financier sent her to Britain in 2010 to have sex with Andrew at Royal Lodge.

Andrew has repeatedly denied any wrongdoing.

He paid a multimillion-pound settlement in 2022 to another Epstein accuser, Virginia Giuffre, without making any admission of guilt.

Andrew stepped back from royal duties in 2019 over his alleged links to Epstein, who died by suicide in jail that year while awaiting trial.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings